Impact of angiographic peri-stent contrast staining (PSS) on late adverse events after sirolimus-eluting stent implantation: An observation from the multicenter j-Cypher registry PSS substudy

Cardiovascular Intervention and Therapeutics

Volumn 29, Issue 3, 2014, Pages 226-236

  Imai, Masao ^a   Kimura, Takeshi ^a   Morimoto, Takeshi ^b   Saito, Naritatsu ^a   Shiomi, Hiroki ^a   Kawaguchi, Ren ^c   Kan, Hakuken ^c   Mukawa, Hiroaki ^d   Fujita, Hiroshi ^e   Ishise, Takuo ^f   Hayashi, Fujio ^g   Nagao, Kazuya ^g   Take, Shunsuke ^h   Taniguchi, Hiromasa ^h   Sakamoto, Hiroki ⁱ   Yamane, Takafumi ⁱ   Shirota, Kinya ^j   Tamekiyo, Hiromichi ^k   Okamura, Takayuki ^l   Kishi, Koichi ^m   Miyazaki, Shinichirou ^m   Yamamoto, Satoshi ⁿ   Yamaji, Kyohei ^o   Kawasaki, Tomohiro ^p   Taguchi, Eiji ^q   Nakajima, Hitoshi ^r   Kosedo, Ippei ^r   Tada, Takeshi ^s   Kadota, Kazushige ^s   Mitsudo, Kazuaki ^s   more..

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c GUNMA PREFECTURAL CARDIOVASCULAR CENTER   (Japan)

^d OGAKI MUNICIPAL HOSPITAL   (Japan)

^e KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^f Maizuru Kyosai Hospital   (Japan)

^g OSAKA RED CROSS HOSPITAL   (Japan)

^h Dept of Respiratory Medicine Saiseikai Noe Hospital   (Japan)

ⁱ NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^j MATSUE RED CROSS HOSPITAL   (Japan)

^k TSUCHIYA GENERAL HOSPITAL   (Japan)

^l YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

^m TOKUSHIMA RED CROSS HOSPITAL   (Japan)

ⁿ Chikamori Medical Group Chikamori Hospital   (Japan)

^o KOKURA MEMORIAL HOSPITAL   (Japan)

^p Shinkoga Hospital   (Japan)

^q SAISEIKAI KUMAMOTO HOSPITAL   (Japan)

^r NATIONAL HOSPITAL ORGANIZATION KAGOSHIMA MEDICAL CENTER   (Japan)

^s KURASHIKI CENTRAL HOSPITAL   (Japan)

more..

Author keywords

Coronary artery disease; Restenosis; Stent; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; ANTIINFLAMMATORY AGENT; CONTRAST MEDIUM; RAPAMYCIN;

ADULT; ADVERSE OUTCOME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INCIDENCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); MULTIVARIATE ANALYSIS; PERI STENT CONTRAST STAINING; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECOMMENDED DRUG DOSE; REGISTER; RISK FACTOR; SIROLIMUS ELUTING STENT; STAINING; STENT THROMBOSIS; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; ADVERSE EFFECTS; BLOOD VESSEL TRANSPLANTATION; CLINICAL TRIAL; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY THROMBOSIS; JAPAN; MULTICENTER STUDY; PROCEDURES; RETROSPECTIVE STUDY;

AGED; ANTI-INFLAMMATORY AGENTS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SIROLIMUS;

EID: 84904421473     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-014-0248-6     Document Type: Article

References (22)

1. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, Shiode N, Namura M, Sone T, Oshima S, Nishikawa H, Hiasa Y, Hayashi Y, Nobuyoshi M, Mitudo K. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry. Circulation. 2012;125(4): 584-91.
2. Yamaji K, Kimura T, Morimoto T, Nakagawa Y, Inoue K, Soga Y, Arita T, Shirai S, Ando K, Kondo K, Sakai K, Goya M, Iwabuchi M, Yokoi H, Nosaka H, Nobuyoshi M. Very long-term (15-20 years) clinical and angiographic outcome after coronary bare metal stent implantation. Circ Cardiovasc Interv. 2010;3(5): 468-75.
3. James SK, Stenestrand U, Lindback J, Carlsson J, Schersten F, Nilsson T, Wallentin L, Lagerqvist B. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med. 2009;360(19): 1933-45.
4. Doyle B, Rihal CS, O'Sullivan CJ, Lennon RJ, Wiste HJ, Bell M, Bresnahan J, Holmes DR Jr. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation. 2007;116(21): 2391-8.
5. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabate M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schomig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356(10): 1030-9.
6. Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, Fuku Y, Hosogi S, Hirono A, Tanaka H, Tada T, Morimoto T, Shiomi H, Kozuma K, Inoue K, Suzuki N, Kimura T, Mitsudo K. Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation. 2011;123(21): 2382-91.
7. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009;119(7): 987-95.
8. Kimura T, Morimoto T, Nakagawa Y, Kadota K, Nozaki Y, Tada T, Take S, Shirota K, Ito A, Nakashima H, Fujita H, Kawasaki T, Inada T, Nakao K, Miyazaki S, Doi O, Isshiki T, Nobuyoshi M, Mitudo K. Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry. Cardiovasc Interv Ther. 2012;27(3): 181-8.
9. Ellis SG. Interventions in acute myocardial infarction. Circulation. 1990;81(3 Suppl): IV43-50.
10. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10): 1020-9.
11. De la Torre-Hernandez JM, Alfonso F, Hernandez F, Elizaga J, Sanmartin M, Pinar E, Lozano I, Vazquez JM, Botas J, de Perez Prado A, Hernandez JM, Sanchis J, Nodar JM, Gomez-Jaume A, Larman M, Diarte JA, Rodriguez-Collado J, Rumoroso JR, Lopez-Minguez JR, Mauri J. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol. 2008;51(10): 986-90.
12. Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, Aizawa T, Mitsudo K, Miyazaki S, Yamaguchi T, Hiyoshi E, Nishimura E, Isshiki T. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the registry of stent thrombosis for review and reevaluation (RESTART). Circulation. 2010;122(1): 52-61.
13. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562): 667-78.
14. Alfonso F, Perez-Vizcayno MJ, Ruiz M, Suarez A, Cazares M, Hernandez R, Escaned J, Banuelos C, Jimenez-Quevedo P, Macaya C. Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol. 2009;53(22): 2053-60.
15. Kon H, Sakai H, Otsubo M, Takano H, Okamoto K, Sato T, Kimura T, Inoue K. Contrast staining outside the sirolimus-eluting stent leading to coronary aneurysm formation: a case of very late stent thrombosis associated with hypersensitivity reaction. Circ Cardiovasc Interv. 2011;4(1): e1-3.
16. Aziz S, Morris JL, Perry RA. Late stent thrombosis associated with coronary aneurysm formation after sirolimus-eluting stent implantation. J Invasive Cardiol. 2007;19(4): E96-8.
17. Lee SE, John SH, Lim JH, Rhew JY. Very late stent thrombosis associated with multiple stent fractures and peri-stent aneurysm formation after sirolimus-eluting stent implantation. Circ J. 2008;72(7): 1201-4.
18. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109(6): 701-5.
19. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48(1): 193-202.
20. Tada T, Kadota K, Hosogi S, Kubo S, Ozaki M, Yoshino M, Miyake K, Eguchi H, Ohashi N, Hayakawa Y, Saito N, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Imai M, Tanaka H, Fuku Y, Oka N, Kato H, Yamamoto H, Fujii S, Goto T, Mitsudo K. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining. Circ Cardiovasc Interv. 2012;5(5): 649-56.
21. Kozuma K, Kimura T, Kadota K, Suwa S, Kimura K, Iwabuchi M, Kawai K, Miyazawa A, Kawamura M, Nakao K, Asano R, Yamamoto T, Suzuki N, Aoki J, Kyono H, Nakazawa G, Tanabe K, Morino Y, Igarashi K. Angiographic findings of everolimus-eluting as compared to sirolimus-eluting stents: angiographic sub-study from the randomized evaluation of sirolimus-eluting versus everolimus-eluting stent trial (RESET). Cardiovasc Interv Ther. 2013;28(4): 344-51.
22. Fujiwara T, Sakakura K, Ako J, Wada H, Arao K, Sugawara Y, Momomura S. Occurrence of late acquired peri-stent contrast staining: comparison between sirolimus-eluting stents and everolimus-eluting stents. Int Heart J. 2012;53(3): 165-9.